Literature DB >> 31794439

A MAPP Network Case-control Study of Urological Chronic Pelvic Pain Compared With Nonurological Pain Conditions.

Niloofar Afari1, Dedra Buchwald2, Daniel Clauw3, Barry Hong4, Xiaoling Hou5, John N Krieger6, Chris Mullins7, Alisa J Stephens-Shields5, Marianna Gasperi1, David A Williams3.   

Abstract

OBJECTIVES: Limited research suggests commonalities between urological chronic pelvic pain syndromes (UCPPS) and other nonurological chronic overlapping pain conditions (COPCs) including fibromyalgia, chronic fatigue syndrome, and irritable bowel syndrome. The goal of this case-control study was to examine similarities and differences between UCPPS and these other COPCs.
MATERIALS AND METHODS: As part of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research (MAPP) Network, we examined 1039 individuals with UCPPS (n=424), nonurological COPCs (n=200), and healthy controls (HCs; n=415). Validated standardized measures were used to assess urological symptoms, nonurological pain symptoms, and psychosocial symptoms and traits.
RESULTS: Participants with UCPPS had more urological symptoms than nonurological COPCs or HCs (P<0.001); nonurological COPC group also had significantly worse urological symptoms than HCs (P<0.001). Participants with nonurological COPCs reported more widespread pain than those with UCPPS (P<0.001), yet both groups had similarly increased symptoms of anxiety, depression, negative affect, perceived stress, neuroticism, and lower levels of extraversion than HCs (P<0.001). Participants with UCPPS with and without COPCs reported more catastrophizing than those with nonurological COPCs (P<0.001). DISCUSSION: Findings are consistent with the hypothesis of common underlying biopsychosocial mechanisms and can guide the comprehensive assessment and treatment of these conditions regardless of the primary site of pain or diagnosis. Heightened catastrophizing in UCPPS should be examined to inform psychosocial interventions and improve patient care.

Entities:  

Mesh:

Year:  2019        PMID: 31794439      PMCID: PMC7055954          DOI: 10.1097/AJP.0000000000000769

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.423


  40 in total

1.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

Review 2.  Advances in the assessment of fibromyalgia.

Authors:  David A Williams; Stephen Schilling
Journal:  Rheum Dis Clin North Am       Date:  2009-05       Impact factor: 2.670

3.  The interstitial cystitis symptom index and problem index.

Authors:  M P O'Leary; G R Sant; F J Fowler; K E Whitmore; J Spolarich-Kroll
Journal:  Urology       Date:  1997-05       Impact factor: 2.649

Review 4.  Does central sensitization help explain idiopathic overactive bladder?

Authors:  W Stuart Reynolds; Roger Dmochowski; Alan Wein; Stephen Bruehl
Journal:  Nat Rev Urol       Date:  2016-06-01       Impact factor: 14.432

5.  Widespread pain: is an improved classification possible?

Authors:  G J MacFarlane; P R Croft; J Schollum; A J Silman
Journal:  J Rheumatol       Date:  1996-09       Impact factor: 4.666

6.  Development and validation of brief measures of positive and negative affect: the PANAS scales.

Authors:  D Watson; L A Clark; A Tellegen
Journal:  J Pers Soc Psychol       Date:  1988-06

7.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.

Authors:  K Fukuda; S E Straus; I Hickie; M C Sharpe; J G Dobbins; A Komaroff
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

8.  The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment.

Authors:  Anne K Rosenstiel; Francis J Keefe
Journal:  Pain       Date:  1983-09       Impact factor: 6.961

9.  Overlap of voiding symptoms, storage symptoms and pain in men and women.

Authors:  J Quentin Clemens; Talar W Markossian; Richard T Meenan; Maureen C O'Keeffe Rosetti; Elizabeth A Calhoun
Journal:  J Urol       Date:  2007-08-16       Impact factor: 7.450

10.  Is the Efficacy of Milnacipran in Fibromyalgia Predictable? A Data-Mining Analysis of Baseline and Outcome Variables.

Authors:  Lilia Abtroun; Pierre Bunouf; Roger M Gendreau; Olivier Vitton
Journal:  Clin J Pain       Date:  2016-05       Impact factor: 3.442

View more
  4 in total

Review 1.  Clinical Management of Bladder Pain Syndrome/Interstitial Cystitis: A Review on Current Recommendations and Emerging Treatment Options.

Authors:  Josie Colemeadow; Arun Sahai; Sachin Malde
Journal:  Res Rep Urol       Date:  2020-08-18

2.  Temporal Relationships between Pain, Mood and Urinary Symptoms in Urological Chronic Pelvic Pain Syndrome: A MAPP Network Study.

Authors:  Bruce D Naliboff; Andrew D Schrepf; Alisa J Stephens-Shields; J Quentin Clemens; Michael A Pontari; Jennifer Labus; Bayley J Taple; Larissa V Rodriguez; Eric Strachan; James W Griffith
Journal:  J Urol       Date:  2021-02-04       Impact factor: 7.600

3.  Clinical efficacy of submucosal injection of triamcinolone acetonide in the treatment of type II/III interstitial cystitis/bladder pain syndrome.

Authors:  Tao Jiang; Xiaozhou Zhou; Zhipeng Chen; Tailin Xiong; Jian Fu; Zhengchao Liu; Dishi Yan; Zhansong Zhou; Wenhao Shen
Journal:  BMC Urol       Date:  2020-03-30       Impact factor: 2.264

Review 4.  Roles of mesenchymal stem cells and exosomes in interstitial cystitis/bladder pain syndrome.

Authors:  Chao Wen; Liping Xie; Chenxia Hu
Journal:  J Cell Mol Med       Date:  2021-12-24       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.